TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6388334

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (Tetracyclines)
Number of subjects: 0
Study: 28884308

Group type: EXPERIMENTAL
Intervention: Usual pharmacological therapy plus 2-week spa therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual pharmacological therapy alone
Number of subjects: 50
Study: 27002953

Group type: EXPERIMENTAL
Intervention: Clopidogrel continued into surgery (group B)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Clopidogrel discontinued 1 week before surgery (group A)
Number of subjects: 39
Study: 24991964

Group type: EXPERIMENTAL
Intervention: Intrinsic network architecture during task performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task-evoked network architecture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resting-state network architecture
Number of subjects: 0
Study: 22622405

Group type: EXPERIMENTAL
Intervention: KB001 3 mg/kg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: KB001 10 mg/kg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: KB001
Number of subjects: 39
Study: 20160047

Group type: EXPERIMENTAL
Intervention: 750 mg lersivirine plus 20 ml Maalox Max
Number of subjects: 0

Group type: COMPARATOR
Intervention: 750 mg lersivirine alone
Number of subjects: 0
Study: 18553042

Group type: EXPERIMENTAL
Intervention: Calcium citrate (500 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Calcium carbonate (1,000 mg)
Number of subjects: 25
Study: 15864622

Group type: EXPERIMENTAL
Intervention: Opposite clear corneal incisions (OCCIs)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no OCCI)
Number of subjects: 57
Study: 12847386

Group type: EXPERIMENTAL
Intervention: Fluconazole (200 mg in isotonic saline)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 71
Study: 16021874

Group type: EXPERIMENTAL
Intervention: stavudine/didanosine
Number of subjects: 151

Group type: COMPARATOR
Intervention: zidovudine/lamivudine
Number of subjects: 151

Group type: COMPARATOR
Intervention: alternating treatment (stavudine/didanosine for 12 weeks followed by zidovudine/lamivudine)
Number of subjects: 151
Study: 9051773

Group type: COMPARATOR
Intervention: Obstacle negotiation during locomotion
Number of subjects: 1

Group type: COMPARATOR
Intervention: Verbal estimates of obstacle height
Number of subjects: 1

Group type: COMPARATOR
Intervention: Toe elevation estimation by raising one leg
Number of subjects: 1
Study: 2064702

Group type: EXPERIMENTAL
Intervention: Taprosten (25 ng/kg bodyweight/minute intravenously)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (30 ml saline solution NaCl 0.9%)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (Taprosten and placebo)
Number of subjects: 22
Study: 6626917

Group type: EXPERIMENTAL
Intervention: Surgical resection
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Surgical by-pass
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Percutaneous prosthesis
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Endoscopic prosthesis
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (for papillary tumours)
Number of subjects: 180
Study: 30536120

Group type: EXPERIMENTAL
Intervention: Panicum maximum supplemented with Lablab purpureus pellets
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Panicum maximum supplemented with Calopogonium mucunoides pellets
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Panicum maximum supplemented with Mucuna pruriens pellets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sole Panicum maximum (control)
Number of subjects: 20
Study: 30311848

Group type: EXPERIMENTAL
Intervention: Nurse Family Partnership plus IPV prevention intervention (NFP+)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Nurse Family Partnership only (Control)
Number of subjects: 238
Study: 26711163

Group type: EXPERIMENTAL
Intervention: Specialized multisession telephone counseling protocol (n=270)
Number of subjects: 577

Group type: COMPARATOR
Intervention: Transfer to state quit-line for counseling (n=307)
Number of subjects: 577
Study: 25192793

Group type: EXPERIMENTAL
Intervention: Active group (12-week Aboriginal and Torres Strait Islander Women's Fitness Program)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlisted group (12-month wait for the program)
Number of subjects: 49
Study: 22853988

Group type: EXPERIMENTAL
Intervention: Intervention group (dietary and cooking classes with mindfulness training)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (wait-list control)
Number of subjects: 36
Study: 20558907

Group type: EXPERIMENTAL
Intervention: Sonazoid (ultrasound contrast agent)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study: 17665488

Group type: EXPERIMENTAL
Intervention: class exercise
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: home exercise using a videotape
Number of subjects: 220

Group type: COMPARATOR
Intervention: control group
Number of subjects: 220
Study: 16118028

Group type: EXPERIMENTAL
Intervention: 11PCV with aluminum adjuvant
Number of subjects: 0

Group type: COMPARATOR
Intervention: 11PCV without aluminum adjuvant
Number of subjects: 0
Study: 12838194

Group type: COMPARATOR
Intervention: Standard regimen (5000 IU 3 times per week for 4 weeks)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Higher dose regimen (10,000 IU 3 times per week)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Once-per-week regimen (15,000 IU once per week)
Number of subjects: 120
Study: 10418864

Group type: EXPERIMENTAL
Intervention: Percutaneous crossed‐pin fixation followed by plaster of Paris cast immobilization
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional plaster of Paris cast immobilization
Number of subjects: 50
Study: 7743787

Group type: EXPERIMENTAL
Intervention: Stepped-care regimen (initial treatment with niacin followed by other agents if needed)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Lovastatin (HMG-CoA reductase inhibitor)
Number of subjects: 612
Study: 2289390

Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg rectal suppository one hour pre-operatively)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31301106

Group type: EXPERIMENTAL
Intervention: Anti-aging biocellulose masks
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lifting biocellulose masks
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Cell renewal biocellulose masks
Number of subjects: 69
Study: 31357685

Group type: EXPERIMENTAL
Intervention: Very Low-Calorie Ketogenic Diet (VLCKD)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Very Low-Calorie Non-Ketogenic Diet (VLCnKD)
Number of subjects: 35
Study: 28673219

Group type: EXPERIMENTAL
Intervention: 1,200 ml carbohydrate solution leading up to admission (up until two hours pre-colonoscopy)
Number of subjects: 398

Group type: COMPARATOR
Intervention: Routine fasting (minimum seven hours)
Number of subjects: 398
Study: 26173719

Group type: EXPERIMENTAL
Intervention: Low-dose CT (LDCT) screening
Number of subjects: 4061

Group type: COMPARATOR
Intervention: Non-participation questionnaire (NPQ)
Number of subjects: 4061
Study: 23889863

Group type: EXPERIMENTAL
Intervention: Dual-coil ICD leads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-coil ICD leads
Number of subjects: 0
Study: 21477333

Group type: EXPERIMENTAL
Intervention: Modified Saliva natura (SN)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glandosane (G)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both saliva substitutes (SN and G)
Number of subjects: 14
Study: 19380444

Group type: EXPERIMENTAL
Intervention: PSA Working Group definition of PSA progression
Number of subjects: 1675

Group type: EXPERIMENTAL
Intervention: Prostate Cancer Working Group (PCWG 2008) definition of PSA progression
Number of subjects: 1675

Group type: COMPARATOR
Intervention: PCWG 2008 definition of PSA-P
Number of subjects: 1675
Study: 16951526

Group type: EXPERIMENTAL
Intervention: Ligustrazine (LI) group
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sodium hyaluronate (SH) group
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study: 15599323

Group type: EXPERIMENTAL
Intervention: Daclizumab 1 mg/kg on day 0 and every 14 days for five doses (group 1, n = 30)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Daclizumab 2 mg/kg on day 0 and on the day of discharge (group 2, n = 22)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Daclizumab 1 mg/kg (group 1)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Daclizumab 2 mg/kg (group 2)
Number of subjects: 52
Study: 11155812

Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg daily
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 9165608

Group type: EXPERIMENTAL
Intervention: Desmopressin (2 micrograms, intravenously)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desmopressin (200 micrograms, orally)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desmopressin treatment (both intravenous and oral)
Number of subjects: 0
Study: 8166777

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 2871285

Group type: EXPERIMENTAL
Intervention: Acetazolamide (Az)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 29363373

Group type: EXPERIMENTAL
Intervention: Short-course low-dose oral prednisolone (tapering doses over 2 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-course low-dose oral prednisolone
Number of subjects: 0
Study: 28481068

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (EPN) in group A
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard fluid therapy in group B
Number of subjects: 44
Study: 25633257

Group type: EXPERIMENTAL
Intervention: Radiofrequency thermotherapy (RF)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Bone-anchored suspension technique (BAST)
Number of subjects: 13
Study: 24231012

Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented group (GlnPN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (Standard PN)
Number of subjects: 30
Study: 21811136

Group type: EXPERIMENTAL
Intervention: Cobicistat 150 mg with atazanavir and emtricitabine/tenofovir df
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ritonavir 100 mg with atazanavir and emtricitabine/tenofovir df
Number of subjects: 0
Study: 19726078

Group type: EXPERIMENTAL
Intervention: Clopidogrel (600 mg loading dose) with PPI
Number of subjects: 13809

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose) without PPI
Number of subjects: 13809

Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg loading dose) with PPI
Number of subjects: 13809

Group type: COMPARATOR
Intervention: Prasugrel (60 mg loading dose) without PPI
Number of subjects: 13809

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 13809

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 13809
Study: 16807438

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GC)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Methotrexate/vinblastine/doxorubicin/cisplatin (MVAC)
Number of subjects: 405
Study: 15296999

Group type: EXPERIMENTAL
Intervention: Driving simulator performance in narcolepsy patients
Number of subjects: 23

Group type: COMPARATOR
Intervention: Driving simulator performance in healthy controls
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neuropsychological testing in narcolepsy patients
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Follow-up investigation after optimising therapy in narcolepsy patients
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Driving simulator performance
Number of subjects: 23
Study: 11255137

Group type: EXPERIMENTAL
Intervention: 1.0-g glycerol x kg body weight(-1) + 30% of the total rehydration water volume (GLY)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 30% of the total rehydration water volume without glycerol (CON)
Number of subjects: 8
Study: 9249117

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 25 mg diluted with saline to 2 mL (12.5 mg/mL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 25 mg diluted with saline to 5 mL (5 mg/mL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 25 mg diluted with saline to 10 mL (2.5 mg/mL)
Number of subjects: 36
Study: 8074624

Group type: EXPERIMENTAL
Intervention: Phenytoin 200 mg
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 2491981

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) IUD
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Copper T 380Ag
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Copper T 220C
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Copper T 200B
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Copper devices (all types)
Number of subjects: 1905

Group type: COMPARATOR
Intervention: All devices
Number of subjects: 1905
Study: 979562

Group type: EXPERIMENTAL
Intervention: Experimental group (vowel-cancelling task on day 2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (heavy interpolated fatigue on the first 3 days)
Number of subjects: 36
Study: 31790543

Group type: EXPERIMENTAL
Intervention: Fenfluramine, 0.4 mg/kg/d (maximum, 17 mg/d)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 87
Study: 31184938

Group type: EXPERIMENTAL
Intervention: 2.8% THC
Number of subjects: 118

Group type: COMPARATOR
Intervention: 0% THC (placebo)
Number of subjects: 118
Study: 29246130

Group type: EXPERIMENTAL
Intervention: Enteral water-soluble vitamin A (5000 IU once a day)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 27311165

Group type: EXPERIMENTAL
Intervention: Laser assisted hatching (quarter technique)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control group (no assisted reproductive techniques)
Number of subjects: 303
Study: 24942766

Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine 10/5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine 20/5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine 40/5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine 40/10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 0
Study: 21883204

Group type: EXPERIMENTAL
Intervention: 8 weeks of joint attention (JA) intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Preschool programs only (control)
Number of subjects: 61
Study: 20022616

Group type: EXPERIMENTAL
Intervention: 1000 microg Cr supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18294111

Group type: EXPERIMENTAL
Intervention: Once-daily abacavir 600 mg-lamivudine 300 mg
Number of subjects: 680

Group type: COMPARATOR
Intervention: Twice-daily abacavir 300 mg and lamivudine 150 mg
Number of subjects: 680
Study: 15738823

Group type: EXPERIMENTAL
Intervention: Mobile-bearing total knee arthroplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed-bearing total knee arthroplasty
Number of subjects: 0
Study: 15307433

Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine (SP) alone (1.25 mg/kg based on pyrimethamine)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Artesunate plus SP (1 dose: 4 mg/kg/d for 1 day)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Artesunate plus SP (3 doses: 4 mg/kg/d for 3 days)
Number of subjects: 600
Study: 10884466

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasound with Valsalva maneuver (VM) for 5 seconds starting 5 seconds after the beginning of contrast injection
Number of subjects: 58

Group type: COMPARATOR
Intervention: Transcranial Doppler ultrasound with no Valsalva maneuver
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasound with VM for 5 seconds starting 2 seconds after the beginning of contrast injection
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasound with VM for 5 seconds starting 8 seconds after the beginning of contrast injection
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasound with repetitive short VMs in between 2 and 13 seconds after the beginning of contrast injection
Number of subjects: 58
Study: 9295836

Group type: EXPERIMENTAL
Intervention: Povidone-iodine (Group 1)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (Group 2)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Povidone-iodine (Group 3)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Povidone-iodine (Group 1) and Chlorhexidine (Group 2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 37
Study: 8314410

Group type: EXPERIMENTAL
Intervention: Nicotinamide group
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 130
Study: 3549705

Group type: EXPERIMENTAL
Intervention: Phenelzine 75 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Imipramine 150 mg
Number of subjects: 27
Study: 31728715

Group type: EXPERIMENTAL
Intervention: Intermittent 5 doses of filgrastim (5 mcg/kg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Once-a-cycle pegfilgrastim (6 mg)
Number of subjects: 22
Study: 29625012

Group type: EXPERIMENTAL
Intervention: Flexibility, toning, and balance DVD (FlexToBa™, FTB)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Healthy aging DVD control
Number of subjects: 307
Study: 27297848

Group type: EXPERIMENTAL
Intervention: Mediterranean diet rich in virgin olive oil
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 1002
Study: 24964913

Group type: EXPERIMENTAL
Intervention: Diazepam auto-injector (AI)
Number of subjects: 129
Study: 22741253

Group type: EXPERIMENTAL
Intervention: Combination group (electroacupuncture + Dalitong granule)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Electroacupuncture group
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Dalitong granule group
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Western medication group
Number of subjects: 500
Study: 20088994

Group type: EXPERIMENTAL
Intervention: Virtual Reality Wii (VRWii)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Recreational Therapy (RT)
Number of subjects: 20
Study: 18450594

Group type: EXPERIMENTAL
Intervention: Interocular disparity measurement using semicircular test and reference stimuli
Number of subjects: 55

Group type: COMPARATOR
Intervention: Reference group of 11 healthy subjects
Number of subjects: 55
Study: 15662532

Group type: EXPERIMENTAL
Intervention: Storage in water for 1 week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Storage in lactic acid solution for 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dentin-restoration resin interfaces
Number of subjects: 0
Study: 12869081

Group type: EXPERIMENTAL
Intervention: Single dose of 750 mg of intravenous cefuroxime
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Patients already receiving antibiotics for prior indications
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 10531745

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated implants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-coated commercially pure titanium implants
Number of subjects: 0
Study: 10159954

Group type: EXPERIMENTAL
Intervention: Passive hyperimmune therapy
Number of subjects: 0
Study: 8495871

Group type: EXPERIMENTAL
Intervention: Postoperative start of thromboprophylaxis with low molecular weight heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 3086899

Group type: EXPERIMENTAL
Intervention: Isosorbide 5-mononitrate 40 mg twice daily
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sustained-release isosorbide dinitrate 40 mg twice daily
Number of subjects: 29
Study: 29485019

Group type: EXPERIMENTAL
Intervention: Directly observed hand hygiene (DOHH) performed at two-hourly intervals during daytime, before meals and medication rounds by a trained nurse.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Volume of alcohol-based hand rub (ABHR) consumed per resident per week in the intervention arm.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonintervention control group (no DOHH).
Number of subjects: 10
Study: 27401505

Group type: EXPERIMENTAL
Intervention: Goals-of-care (GoC) intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 25111705

Group type: EXPERIMENTAL
Intervention: Standard instructions for APS‐R
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Variation prompting normal distribution consideration
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Visual analog (slider) scale for APS‐R
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Statistical transformations of perfectionism scores
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Criterion indicators of emotion regulation (reappraisal or suppression), perceived stress, and depression
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Maladaptive perfectionists
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Adaptive perfectionists
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Both perfectionist classes
Number of subjects: 506
Study: 22180390

Group type: EXPERIMENTAL
Intervention: Virtual reality cognitive-behavior therapy (VRCBT)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 88
Study: 20143246

Group type: EXPERIMENTAL
Intervention: Topiramate 25 mg/day
Number of subjects: 0
Study: 18677327

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (part of a 4-year randomized controlled trial)
Number of subjects: 23
Study: 16447471

Group type: EXPERIMENTAL
Intervention: Tensiometer feedback combined with subjective feedback
Number of subjects: 12

Group type: COMPARATOR
Intervention: Subjective feedback only
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tensiometer feedback only
Number of subjects: 12

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 12
Study: 12860210

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg
Number of subjects: 45